The 2-13C-5-fluorouracil breath test (FUBT) as a novel, rapid method for assessment of dihydropyrimidine dehydrogenase (DPD) activity in cancer patients: Initial characterization and comparison to the 2-13C-uracil breath test (UraBT)

被引：0
|
作者：
Fourie, J.
Mattison, L. K.
Wood, T. E.
Posey, J. A., III
Modak, A.
Diasio, R. B.
机构：
[1] Mayo Clin, Ctr Canc, Rochester, MN USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Cambridge Isotope Labs Inc, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2551
引用
收藏
页数：1
相关论文
共 25 条
  • [21] CORRELATION BETWEEN CYTOCHROME P450 2C19 ENZYMATIC ACTIVITY ASSESSED BY [13C]-PANTOPRAZOLE BREATH TEST AND PLATELET REACTIVITY IN PATIENTS TREATED WITH CLOPIDOGREL AFTER PERCUTANEOUS CORONARY INTERVENTION
    Harvey, A.
    Dery, U.
    Roy, M.
    Modak, A.
    Rinfret, S.
    Bertrand, O. F.
    Larose, E.
    Rodes-Cabau, J.
    Barbeau, G.
    Gleeton, O.
    Nguyen, C. M.
    Proulx, G.
    Noel, B.
    Roy, L.
    DeLarochelliere, R.
    Dery, J. P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S152 - S152
  • [22] The effect of proton pump inhibitors on the CYP2C19 enzyme activity evaluated by the pantoprazole-13C breath test in GERD patients: clinical relevance for personalized medicine (vol 10, 046017, 2016)
    Modak, Anil S.
    Klyarytska, Iryna
    Kriviy, Valerij
    Tsapyak, Tatjana
    Rabotyagova, Yliya
    JOURNAL OF BREATH RESEARCH, 2017, 11 (02)
  • [23] The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
    Opdam, F. L.
    Dezentje, V. O.
    den Hartigh, J.
    Modak, A. S.
    Vree, R.
    Batman, E.
    Smorenburg, C. H.
    Nortier, J. W. R.
    Gelderblom, H.
    Guchelaar, H. -J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 593 - 601
  • [24] The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
    F. L. Opdam
    V. O. Dezentje
    J. den Hartigh
    A. S. Modak
    R. Vree
    E. Batman
    C. H. Smorenburg
    J. W. R. Nortier
    H. Gelderblom
    H.-J. Guchelaar
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 593 - 601
  • [25] Erratum to: The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
    F. L. Opdam
    V. O. Dezentje
    J. den Hartigh
    A. S. Modak
    R. Vree
    E. Batman
    C. H. Smorenburg
    J. W. R. Nortier
    H. Gelderblom
    H.-J. Guchelaar
    Cancer Chemotherapy and Pharmacology, 2013, 71 (3) : 603 - 603
123